Yahoo Finance 
Insights on the T-cell Lymphoma Global Market to 2028 - by Lymphoma Type, Therapy and Region
T-cell Lymphoma Market
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
Lymphoma is the most common type of blood cancer which occurs when white blood cells called lymphocytes grow and multiply uncontrollably in the human body. Lymphocytes are a part of the immune system of the body, which travel around the body through the lymphatic system and help fight microbial infection.
Lymphocytes are of two types B lymphocytes (B-cells) and T lymphocytes (T-cells). Lymphomas that develop from T lymphocytes are known as non-Hodgkin lymphomas. T-cell lymphoma can affect body parts including spleen, lymph node, bone marrow, blood, and others. T-cell lymphoma can be majorly categorized into two types i.e. peripheral T-cell lymphoma and T-cell lymphoblastic lymphoma. The symptoms associated with T-cell lymphoma depend upon the type of T-cell lymphoma. One of the most common symptom of t-cell lymphoma includes swollen lymph node or nodes. Other symptoms include swollen liver or spleen, skin rash, abnormal blood cell count, and others.
Market Dynamics
The increasing incidence of T-cell lymphoma, rising research and development activities for the development of novel therapeutics for the treatment of T-cell lymphoma are the major factors that are expected to drive growth of the global T-cell lymphoma market over the forecast period. Moreover, increasing adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market are expected to boost the global T-cell lymphoma market.
For instance, according to a review article published in the CA: A Cancer Journal for Clinicians in December 2019, it has been estimated that there are around 80,000 people suffering from non-Hodgkin lymphomas (NHL) per year in U.S. and this is expected to increase in the near future.
Key features of the study:
This report provides in-depth analysis of the global T-cell lymphoma market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global T-cell lymphoma market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Biocryst Pharmaceuticals Inc., Bristol-Myers Squibb Company, Kyowa Kirin Co., Ltd., Genmab A/S, Seagen Inc., GlaxoSmithKline plc., Johnson and Johnson Private Limited, Elorac, Acrotech Biopharma, Merck and Co. Inc., Novartis AG, SHIONOGI & Co., Ltd., Spectrum Pharmaceuticals Inc., and Bausch Health Companies Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global T-cell lymphoma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global T-cell lymphoma market
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Lymphoma Type
Market Snippet, By Therapy
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Reimbursement Scenario
Mergers & Acquisitions
4. Global T-cell Lymphoma Market - Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
Impact on Clinical Trials and Drug Development
Government Initiatives
5. Global T-cell Lymphoma Market, By Lymphoma Type, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Peripheral T-cell Lymphoma
Cutaneous T-cell Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Anaplastic Large Cell Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Angio-immuno-blastic T-cell Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others (Intestinal T-cell Lymphoma, Follicular T-cell lymphoma, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
T-cell Lymphoblastic Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global T-cell Lymphoma Market, By Therapy , 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2018 - 2028
Segment Trends
Radiotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Stem Cell Transplantation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others (Antiviral Therapy, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global T-cell Lymphoma Market, By Region, 2017 - 2028, (US$ Mn)
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
F. Hoffmann-La Roche Ltd
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Biocryst Pharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol-Myers Squibb Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Kyowa Kirin Co., Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Genmab A/S
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Seagen Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline plc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson and Johnson Private Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Elorac
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Acrotech Biopharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck and Co. Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
SHIONOGI & Co., Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Spectrum Pharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bausch Health Companies Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/y7cy7n
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
